knowledge -WSS

knowledge

author：hotspot 2025-08-12 09:08:59 - browse：5581

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Hospitals look to new technology to keep health care workers safe

WSS

Stanford president faces new allegations over 1999 paper

Congress must reauthorize a committee to support older Americans

Hospitals look to new technology to keep health care workers safe

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Congress must reauthorize a committee to support older Americans

entertainment

knowledge

entertainment

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Hepatitis C has a cure — but many Americans still lack access to it

Surge of respiratory disease in China has likely explanation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospitals struggle to profit from CAR

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA's Woodcock to retire early next year

hotspot

Why medical students are struggling with mental health

Gain of function research would be limited under House proposal

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Tocagen's brain cancer gene therapy trial continues. Investors worry

hotspot

Wikipedia

explore

explore